Key result
A medication to bedside delivery service did not significantly reduce 30-day hospital reutilization compared to standard discharge (8.0% vs 10.0%; OR 0.78; 95% CI 0.45-1.37).
Why the study?
The study was conducted to evaluate the impact of a medication to bedside delivery (meds-to-beds) service on hospital reutilization in an adult population.
Does medication to bedside delivery service reduce 30-day hospital reutilization in adult patients discharged from an internal medicine unit?
Population
600 adult patients discharged from an internal medicine unit with at least one maintenance medication
Comparison
Meds-to-beds service vs no meds-to-beds service
Design
Retrospective, single-center, observational cohort study
Follow-up
30 days
Authors
Loading...
Does not support routine bedside delivery adoption; leaves open whether randomized trials might detect reutilization benefit.
Cohort (n=600)
No
Does medication to bedside delivery service reduce 30-day hospital reutilization in adult patients discharged from an internal medicine unit?
Odds Ratio: 0.78 (95% CI 0.45–1.37)
Absolute Event Rate: 8% vs 10%
A medication to bedside delivery service alone did not significantly reduce 30-day hospital reutilization in adult internal medicine patients.
Patel et al. (2019) conducted a cohort in Discharged internal medicine patients (n=600). Medication to bedside delivery (meds-to-beds) service vs. No meds-to-beds service was evaluated on 30-day hospital reutilization (emergency department visits and/or hospital readmissions) related to the index visit (OR 0.78, 95% CI 0.45-1.37). A medication to bedside delivery service did not significantly reduce 30-day hospital reutilization compared to standard discharge (8.0% vs 10.0%; OR 0.78; 95% CI 0.45-1.37).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: